Chronic exposure to aluminum and melatonin through the diet: Neurobehavioral effects in a transgenic mouse model of Alzheimer disease

Food and Chemical Toxicology

Volumn 69, Issue , 2014, Pages 320-329

  Di Paolo, Celeste ^a   Reverte, Ingrid ^a,b   Colomina, Maria Teresa ^a,b   Domingo, José L ^a   Gómez, Mercedes ^a  

^a INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Aluminum; Alzheimer disease; Behavior; Melatonin; Tg2576

Indexed keywords

ALUMINUM; CITRIC ACID; MELATONIN; ANXIOLYTIC AGENT;

ADULT; ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; DIET; FEMALE; LEARNING; LONG TERM EXPOSURE; MALE; MEMORY CONSOLIDATION; MORRIS WATER MAZE TEST; MOUSE; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; SPATIAL MEMORY; TASK PERFORMANCE; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; GENETICS; MAZE TEST; TOXICITY TESTING;

ALUMINUM; ALZHEIMER DISEASE; ANIMALS; ANTI-ANXIETY AGENTS; CITRIC ACID; DIET; DISEASE MODELS, ANIMAL; FEMALE; MALE; MAZE LEARNING; MELATONIN; MICE, INBRED C57BL; MICE, TRANSGENIC; SPATIAL MEMORY; TOXICITY TESTS, CHRONIC;

EID: 84901238490     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2014.04.022     Document Type: Article

References (64)

1. Akbulut K.G., Gonül B., Akbulut H. Exogenous melatonin decreases age-induced lipid peroxidation in the brain. Brain Res. 2008, 1238:31-35.
2. Antunes Wilhelm E., Ricardo Jesse C., Folharini Bortolatto C., Wayne Nogueira C. Correlations between behavioural and oxidative parameters in a rat quinolinic acid model of Huntington's disease: protective effect of melatonin. Eur. J. Pharmacol. 2013, 701:65-72.
3. Arnich N., Sirot V., Riviere G., Jean J., Noel L., Guerin T., Leblanc J.C. Dietary exposure to trace elements and health risk assessment in the 2nd French Total Diet Study. Food Chem. Toxicol. 2012, 50:2432-2449.
4. Baño Otalora B., Popovic N., Gambini J., Popovic M., Viña J., Bonet-Costa V., Reiter R.J., Camello P.J., Rol M.Á., Madrid J.A. Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon. Chronobiol. Int. 2012, 29:822-834.
5. Bizon J., Prescott S., Nicolle M.M. Intact spatial learning in adult Tg2576 mice. Neurobiol. Aging. 2007, 28:440-446.
6. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
7. Bubenik G.A., Konturek S.J. Melatonin and aging: prospects for human treatment. J. Physiol. Pharmacol. 2011, 62:13-19.
8. Colomina M.T., Roig J.L., Sánchez D.J., Domingo J.L. Influence of age on aluminum-induced neurobehavioral effects and morphological changes in rat brain. Neurotoxicology 2002, 23:775-781.
9. Corrales A., Martínez P., García S., Vidal V., García E., Flórez J., Sanchez-Barceló E.J., Martínez-Cué C., Rueda N. Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome. J. Pineal Res. 2013, 54:346-358.
10. Domingo J.L., Gómez M., Sánchez D.J., Llobet J.M., Corbella J. Effect of various dietary constituents on gastrointestinal absorption of aluminum from drinking water and diet. Res. Commun. Chem. Pathol. Pharmacol. 1993, 79:377-380.
11. Esparza J.L., Gómez M., Nogués M.R., Paternain J.L., Mallol J., Domingo J.L. Melatonin reduces oxidative stress and increases gene expression in the cerebral cortex and cerebellum of aluminum-exposed rats. J. Pineal Res. 2005, 39:129-136.
12. Fekete V., Vandevijvere S., Bolle F., Van Loco J. Estimation of dietary aluminum exposure of the Belgian adult population: evaluation of contribution of food and kitchenware. Food Chem. Toxicol. 2013, 55:602-608.
13. García T., Ribes D., Colomina M.T., Cabré M., Domingo J.L., Gómez M. Evaluation of the protective role of melatonin on the behavioral effects of aluminum in a mouse model of Alzheimer's disease. Toxicology 2009, 265:49-55.
14. García T., Esparza J.L., Nogués M.R., Romeu M., Domingo J.L., Gómez M. Oxidative stress status and RNA expression in hippocampus of an animal model of Alzheimer's disease after chronic exposure to aluminum. Hippocampus 2010, 20:218-225.
15. Golub M.S. Behavioral studies in animals: past and potential contribution to the understanding of the relationship between aluminum and Alzheimer's disease. Aluminum and Alzheimer's disease 2001, 169-187. Elsevier. C. Exley (Ed.).
16. Golub M.S., Germann S.L. Long-term consequences of developmental exposure to aluminum in a suboptimal diet for growth and behavior of Swiss Webster mice. Neurotoxicol. Teratol. 2001, 23:365-372.
17. Golub M.S., Keen C.L. Effects of dietary aluminum on pubertal mice. Neurotoxicol. Teratol. 1999, 21:595-602.
18. Gómez M., Esparza J.L., Nogués M.R., Giralt M., Cabré M., Domingo J.L. Pro-oxidant activity of aluminum in the rat hippocampus: gene expression of antioxidant enzymes after melatonin administration. Free Radical Biol. Med. 2005, 38:104-111.
19. Gómez M., Esparza J.L., Cabré M., García T., Domingo J.L. Aluminum exposure through the diet: metal levels in AbetaPP transgenic mice a model for Alzheimer's disease. Toxicology 2008, 249:214-219.
20. Greger J.L. Aluminum metabolism. Annu. Rev. Nutr. 1993, 13:43-63.
21. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits Abeta elevation and amyloid plaques in transgenic mice. Science 1996, 274:99-102.
22. Jing Y., Wang Z., Song Y. Quantitative study of aluminum-induced changes in synaptic ultrastructure in rats. Synapse 2004, 52:292-298.
23. Karbouj R., Desloges I., Nortier P. A simple pre-treatment of aluminium cookware to minimize aluminium transfer to food. Food Chem. Toxicol. 2009, 47:571-577.
24. Kawahara M., Kato M., Kuroda Y. Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein. Brain Res. Bull. 2001, 55:211-217.
25. King D.L., Arendash G.W. Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19months. Physiol. Behav. 2002, 75:627-642.
26. King D.L., Arendash G.W., Crawford F., Sterk T., Menendez J., Mullan M.J. Progressive and gender-dependent cognitive impairment in the APP (SW) transgenic mouse model for Alzheimer's disease. Behav. Brain Res. 1999, 103:145-162.
27. Kováks T., Cairns N.J., Lantos P.L. Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. NeuroReport 2001, 12:285-288.
28. Lack B., Daya S., Nyokong T. Interaction of serotonin and melatonin with sodium, potassium, calcium, lithium and aluminum. J. Pineal Res. 2001, 31:102-108.
29. Lalonde R., Lewis T.L., Strazielle C., Kim H., Fukuchi K. Transgenic mice expressing the betaAPP695SWE mutation: effects on exploratory activity anxiety and motor coordination. Brain Res. 2003, 977:38-45.
30. Liu X.J., Yuan L., Yang D., Han W.N., Li Q.S., Yang W., Liu Q.S., Qi J.S. Melatonin protects against amyloid-β-Induced impairments of hippocampal LTP and spatial learning in rats. Synapse 2013, 67:626-636.
31. Magaia T., Uamusse A., Sjöholm I., Skog K. Dietary fiber, organic acids and minerals in selected wild edible fruits of Mozambique. SpringerPlus 2013, 2:88.
32. Mauriz J.L., Collado P.S., Veneroso C., Reiter R.J., González-Gallego J. A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives. J. Pineal Res. 2013, 54:1-14.
33. McKenna J.T., Christie M.A., Jeffrey B.A., McCoy J.G., Lee E., Connolly N.P., Ward C.P., Strecker R.E. Chronic ramelteon treatment in a mouse model of Alzheimer's disease. Arch. Ital. Biol. 2012, 150:5-14.
34. Miu A.C., Andreescu C.E., Vasiu R., Olteanu A.I. A behavioral and histological study of the effects of long-term exposure of adult rats to aluminum. Int. J. Neurosci. 2003, 113:1197-1211.
35. Olcese J.M., Cao C., Mori T., Mamcarz M.B., Maxwell A., Runfeldt M.J., Wang L., Zhang C., Lin X., Zhang G., Arendash G.W. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. J. Pineal Res. 2009, 47:82-96.
36. Pandi-Perumal S.R., Srinivasan V., Maestroni G.J., Cardinali D.P., Poeggeler B., Hardeland R. Melatonin. Nature's most versatile biological signal?. FEBS J. 2006, 273:2813-2838.
37. Percy M.E., Kruck T.P., Pogue A.I., Lukiw W.J. Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer's disease. J. Inorg. Biochem. 2011, 105:1505-1512.
38. Praticò D., Uryu K., Sung S., Tang S., Trojanowski J.Q., Lee V.M. Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J. 2002, 16:1138-1140.
39. Reiter R.J. The melatonin rhythm: both a clock and a calendar. Experientia 1993, 49:654-664.
40. Reiter R.J. The pineal gland and melatonin in relation to aging: a summary of the theories and of the data. Exp. Gerontol. 1995, 30:199-212.
41. Reiter R.J., Tan D.X., Fuentes-Broto L. Melatonin: a multitasking molecule. Prog. Brain Res. 2010, 181:127-151.
42. Ribes D., Colomina M.T., Vicens P., Domingo J.L. Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic mouse model of Alzheimer's disease. Exp. Neurol. 2008, 214:293-300.
43. Ribes D., Colomina M.T., Vicens P., Domingo J.L. Impaired spatial learning and unaltered neurogenesis in a transgenic model of Alzheimer's disease after oral aluminum exposure. Curr. Alzheimer Res. 2010, 7:401-408.
44. Rodella L.F., Ricci F., Borsani E. Aluminium exposure induces Alzheimer's disease-like histopathological alterations in mouse brain. Histol. Histopathol. 2008, 23:433-439.
45. Rodella L.F., Favero G., Rossini C., Foglio E., Bonomini F., Reiter R.J., Rezzani R. Aging and vascular dysfunction: beneficial melatonin effects. Age (Dordr) 2013, 35:103-115.
46. Rodgers S.P., Born H.A., Das P., Jankowsky J.L. Transgenic APP expression during postnatal development causes persistent locomotor hyperactivity in the adult. Mol Neurodegener 2012, 18:7-28.
47. Roig J.L., Fuentes S., Colomina M.T., Vicens P., Domingo J.L. Aluminum restraint stress and aging: behavioral effects in rats after 1 and 2 years of aluminum exposure. Toxicology 2006, 218:112-124.
48. Silva A.F., Aguiar M.S., Carvalho O.S., Santana L.N., Franco E.C., Lima R.R., Siqueira N.V., Faro L.R., Gomes-Leal W. Hippocampal neuronal loss decreased GFAP immunoreactivity and cognitive impairment following experimental intoxication of rats with aluminum citrate. Brain Res. 2013, 1491:23-33.
49. Walton J.R. Functional impairment in aged rats chronically exposed to human range dietary aluminum equivalents. Neurotoxicology 2009, 30:182-193.
50. Walton J.R. Cognitive deterioration and associated pathology induced by chronic low-level aluminum ingestion in a translational rat model provides an explanation of Alzheimer's disease, tests for susceptibility and avenues for treatment. Int. J. Alzheimers Dis. 2012, 2012:914947. 10.1155/2012/914947.
51. Walton J.R. Evidence that ingested aluminum additives contained in processed foods and alum-treated drinking water are a major risk factor for Alzheimer's disease. Curr. Inorg. Chem. 2012, 2:19-39.
52. Walton J.R. Aluminum involvement in the progression of Alzheimer's disease. J. Alzheimers Dis. 2013, 35:7-43.
53. Westerman M.A., Cooper-Blacketer D., Mariash A., Kotilinek L., Kawarabayashi T., Younkin L.H., Carlson G.A., Younkin S.G., Ashe K.H. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 2002, 22:1858-1867.
54. Whitehead M.W., Farrar G., Christie G.L., Blair J.A., Thompson R.P., Powell J.J. Mechanisms of aluminum absorption in rats. Am. J. Clin. Nutr. 1997, 65:1446-1452.
55. World Health Organization, 1989. Aluminium in: 657. Aluminium (WHO Food Additive Series 24),http://www.inchem.org/documents/jecfa/jecmono/v024je07.htm.
56. World Health Organization, 2007. Evaluation of certain food additives and contaminants in Sixty-seventh report of the joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series http://www.who.int/ipcs/publications/jecfa/reports/trs940.pdf.
57. Wu X., Li J., Hu J.N., Deng Z.Y. The effects of glutamate and citrate on absorption and distribution of aluminum in rats. Biol. Trace Elem. Res. 2012, 14:83-90.
58. Yilmaz, S., Unal, F., Yüzbasioglu, D., Celik, M., 2012. DNA damage in human lymphocytes exposed to four food additives in vitro. Toxicol. Ind. Health PMID: 23188648.
59. Yokel R.A. The toxicology of aluminum in the brain: a review. Neurotoxicology 2000, 21:813-828.
60. Yokel R.A. Aluminum. Encyclopedia of Human Nutrition 2013, 57-63. Elsevier, http://dx.doi.org/10.1016/B978-0-12-375083-9.00008-8. third ed. B. Caballero (Ed.).
61. Yokel R.A., Florence R.L. Aluminum bioavailability from tea infusion. Food Chem. Toxicol. 2008, 46:3659-3663.
62. Yumoto S., Kakimi S., Ohsaki A., Ishikawa A. Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer's disease. J. Inorg. Biochem. 2009, 103:1579-1584.
63. Zhang Q.L., Jia L., Jiao X., Guo W.L., Ji J.W., Yang H.L., Niu Q. APP/PS1 transgenic mice treated with aluminum: an update of Alzheimer's disease model. Int. J. Immunopathol. Pharmacol. 2012, 25:49-58.
64. Zhou Y., Harris W.R., Yokel R.A. The influence of citrate, maltolate and fluoride on the gastrointestinal absorption of aluminum at a drinking water-relevant concentration: a 26Al and 14C study. J. Inorg. Biochem. 2008, 102:798-808.